Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jensen, E. V.
Right arrow Articles by Jordan, V. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jensen, E. V.
Right arrow Articles by Jordan, V. C.
Clinical Cancer Research Vol. 9, 1980-1989, June 2003
© 2003 American Association for Cancer Research

Special Article

The Estrogen Receptor

A Model for Molecular Medicine1

Elwood V. Jensen and V. Craig Jordan2

Department of Cell Biology, Vontz Center for Molecular Studies, University of Cincinnati, Ohio 45267 [E. V. J.], and Robert H. Lurie Comprehensive Cancer Center, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611 [V. C. J.]

ABSTRACT

The identification of the estrogen receptor (ER) in the laboratory provided a mechanism to describe the target site specificity of estrogen action in uterus, vagina, pituitary gland, and breast cancer. Most importantly, a test was established to predict the outcome of antihormonal therapy in breast cancer, and a target was identified to develop new drugs for the treatment and prevention of breast cancer. The development of tamoxifen for the treatment of all stages of ER-positive breast cancers has resulted in the improved survival of breast cancer patients. However, the recognition of selective ER modulation, i.e., estrogen-like action in bones and lowering circulating cholesterol but antiestrogenic actions in breast and uterus, has resulted in the development of multifunctional medicines with the goal of preventing not only breast and uterine cancer but also osteoporosis and coronary heart disease.




This article has been cited by other articles:


Home page
 JCOHome page
V. C. Jordan
The 38th David A. Karnofsky Lecture: The Paradoxical Actions of Estrogen in Breast Cancer--Survival or Death?
J. Clin. Oncol., June 20, 2008; 26(18): 3073 - 3082.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
J. K. Nagpal, S. Nair, D. Chakravarty, R. Rajhans, S. Pothana, D. W. Brann, R. R. Tekmal, and R. K. Vadlamudi
Growth Factor Regulation of Estrogen Receptor Coregulator PELP1 Functions via Protein Kinase A Pathway
Mol. Cancer Res., May 1, 2008; 6(5): 851 - 861.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. Rajhans, H. B. Nair, S. S. Nair, V. Cortez, K. Ikuko, N. B. Kirma, D. Zhou, A. E. Holden, D. W Brann, S. Chen, et al.
Modulation of in Situ Estrogen Synthesis by Proline-, Glutamic Acid-, and Leucine-Rich Protein-1: Potential Estrogen Receptor Autocrine Signaling Loop in Breast Cancer Cells
Mol. Endocrinol., March 1, 2008; 22(3): 649 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
N. Picard, C. Charbonneau, M. Sanchez, A. Licznar, M. Busson, G. Lazennec, and A. Tremblay
Phosphorylation of Activation Function-1 Regulates Proteasome-Dependent Nuclear Mobility and E6-Associated Protein Ubiquitin Ligase Recruitment to the Estrogen Receptor {beta}
Mol. Endocrinol., February 1, 2008; 22(2): 317 - 330.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
T. J. Grifone, H. M. Haupt, V. Podolski, and J. J. Brooks
Immunohistochemical Expression of Estrogen Receptors in Chondrosarcomas and Enchondromas
International Journal of Surgical Pathology, January 1, 2008; 16(1): 31 - 37.
[Abstract] [PDF]

Home page
 Ann OncolHome page
H. S. Rugo
The breast cancer continuum in hormone-receptor positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors
Ann. Onc., January 1, 2008; 19(1): 16 - 27.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
V. C. Jordan and B. W. O'Malley
Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast Cancer
J. Clin. Oncol., December 20, 2007; 25(36): 5815 - 5824.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
V. C. Jordan
Tamoxifen or Raloxifene for Breast Cancer Chemoprevention: A Tale of Two Choices Point
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2207 - 2209.
[Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
L. Vona-Davis and D. P Rose
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
Endocr. Relat. Cancer, June 1, 2007; 14(2): 189 - 206.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
V. C. Jordan and R. D. Gelber
Problems With the Progesterone Receptor in Practice?
J. Clin. Oncol., May 20, 2007; 25(15): 1957 - 1959.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Zhao, J. Matthews, M. Tujague, J. Wan, A. Strom, G. Toresson, E. W-F. Lam, G. Cheng, J.-A. Gustafsson, and K. Dahlman-Wright
Estrogen Receptor {beta}2 Negatively Regulates the Transactivation of Estrogen Receptor {alpha} in Human Breast Cancer Cells
Cancer Res., April 15, 2007; 67(8): 3955 - 3962.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
V. C. Jordan
SERMs: Meeting the Promise of Multifunctional Medicines
J Natl Cancer Inst, March 7, 2007; 99(5): 350 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
K. Dahlman-Wright, V. Cavailles, S. A. Fuqua, V. C. Jordan, J. A. Katzenellenbogen, K. S. Korach, A. Maggi, M. Muramatsu, M. G. Parker, and J.-A. Gustafsson
International Union of Pharmacology. LXIV. Estrogen Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 773 - 781.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Belosay, A. M.H. Brodie, and V. C.O. Njar
Effects of Novel Retinoic Acid Metabolism Blocking Agent (VN/14-1) on Letrozole-Insensitive Breast Cancer Cells
Cancer Res., December 1, 2006; 66(23): 11485 - 11493.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
R. PONZONE, N. BIGLIA, M. E. JACOMUZZI, L. MARIANI, A. DOMINGUEZ, and P. SISMONDI
Antihormones in Prevention and Treatment of Breast Cancer
Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 143 - 158.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. de Medina, N. Boubekeur, P. Balaguer, G. Favre, S. Silvente-Poirot, and M. Poirot
The Prototypical Inhibitor of Cholesterol Esterification, Sah 58-035 [3-[Decyldimethylsilyl]-N-[2-(4-methylphenyl)-1-phenylethyl]propanamide], Is an Agonist of Estrogen Receptors
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 139 - 149.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. E. O'Brien, T. J. Peterson, M. H. Tong, E.-J. Lee, L. E. Pfaff, S. C. Hewitt, K. S. Korach, J. Weiss, and J. L. Jameson
Estrogen-induced Proliferation of Uterine Epithelial Cells Is Independent of Estrogen Receptor {alpha} Binding to Classical Estrogen Response Elements
J. Biol. Chem., September 8, 2006; 281(36): 26683 - 26692.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Lupu and J. A. Menendez
Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?
Endocrinology, September 1, 2006; 147(9): 4056 - 4066.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. C. Jordan
The Science of Selective Estrogen Receptor Modulators: Concept to Clinical Practice
Clin. Cancer Res., September 1, 2006; 12(17): 5010 - 5013.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. K. Rayala, P. den Hollander, B. Manavathi, A. H. Talukder, C. Song, S. Peng, A. Barnekow, J. Kremerskothen, and R. Kumar
Essential Role of KIBRA in Co-activator Function of Dynein Light Chain 1 in Mammalian Cells
J. Biol. Chem., July 14, 2006; 281(28): 19092 - 19099.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al.
Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward
Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
V. C. Jordan
Pak up your breast tumor--and grow!
J Natl Cancer Inst, May 17, 2006; 98(10): 657 - 659.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
S. K. Rayala, A. H. Talukder, S. Balasenthil, R. Tharakan, C. J. Barnes, R.-A. Wang, M. Aldaz, S. Khan, and R. Kumar
P21-Activated Kinase 1 Regulation of Estrogen Receptor-{alpha} Activation Involves Serine 305 Activation Linked with Serine 118 Phosphorylation
Cancer Res., February 1, 2006; 66(3): 1694 - 1701.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. B. Runnebaum and A. Bruning
Glucocorticoids Inhibit Cell Death in Ovarian Cancer and Up-regulate Caspase Inhibitor cIAP2
Clin. Cancer Res., September 1, 2005; 11(17): 6325 - 6332.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
V. C. Jordan
Medroxyprogesterone Acetate and Metastases: Of Mice and (wo)Men
J Natl Cancer Inst, May 4, 2005; 97(9): 619 - 621.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Vazquez-Martin, R. Colomer, S. Ropero, J. Abel Menendez, A. Argiris, C.-X. Wang, D. C. Koay, and M. P. DiGiovanna
Growth and Molecular Interactions between Tamoxifen and Trastuzumab
Clin. Cancer Res., May 1, 2005; 11(9): 3597 - 3597.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Geisler and P. E. Lonning
Aromatase Inhibition: Translation into a Successful Therapeutic Approach
Clin. Cancer Res., April 15, 2005; 11(8): 2809 - 2821.
[Abstract] [Full Text] [PDF]

Home page
 aacrmtgHome page
V. C. Jordan
Targeting the estrogen receptor to treat and prevent breast cancer
AACR Meeting Abstracts, April 1, 2005; 2005(1): 1457 - 1457.
[Abstract]

Home page
 JCOHome page
C. J. Fabian and B. F. Kimler
Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer
J. Clin. Oncol., March 10, 2005; 23(8): 1644 - 1655.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Liu, S. Edgerton, X. Yang, A. Kim, D. Ordonez-Ercan, T. Mason, K. Alvarez, C. McKimmey, N. Liu, and A. Thor
Low-Dose Dietary Phytoestrogen Abrogates Tamoxifen-Associated Mammary Tumor Prevention
Cancer Res., February 1, 2005; 65(3): 879 - 886.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. M. Boyapati, X. O. Shu, Z. X. Ruan, Q. Cai, J. R. Smith, W. Wen, Y.-T. Gao, and W. Zheng
Polymorphisms in ER-{alpha} Gene Interact with Estrogen Receptor Status in Breast Cancer Survival
Clin. Cancer Res., February 1, 2005; 11(3): 1093 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. K. Vadlamudi, S. Balasenthil, R. R. Broaddus, J.-A. Gustafsson, and R. Kumar
Deregulation of Estrogen Receptor Coactivator Proline-, Glutamic Acid-, and Leucine-Rich Protein-1/Modulator of Nongenomic Activity of Estrogen Receptor in Human Endometrial Tumors
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6130 - 6138.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y.-W. Leu, P. S. Yan, M. Fan, V. X. Jin, J. C. Liu, E. M. Curran, W. V. Welshons, S. H. Wei, R. V. Davuluri, C. Plass, et al.
Loss of Estrogen Receptor Signaling Triggers Epigenetic Silencing of Downstream Targets in Breast Cancer
Cancer Res., November 15, 2004; 64(22): 8184 - 8192.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. S. Nair, S. K. Mishra, Z. Yang, S. Balasenthil, R. Kumar, and R. K. Vadlamudi
Potential Role of a Novel Transcriptional Coactivator PELP1 in Histone H1 Displacement in Cancer Cells
Cancer Res., September 15, 2004; 64(18): 6416 - 6423.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
C. Osipo, H. Liu, K. Meeke, and V. C. Jordan
The Consequences of Exhaustive Antiestrogen Therapy in Breast Cancer: Estrogen-Induced Tumor Cell Death
Experimental Biology and Medicine, September 1, 2004; 229(8): 722 - 731.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. C. Murphy, Y. Niu, L. Snell, and P. Watson
Phospho-Serine-118 Estrogen Receptor-{alpha} Expression Is Associated with Better Disease Outcome in Women Treated with Tamoxifen
Clin. Cancer Res., September 1, 2004; 10(17): 5902 - 5906.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
V. C. Jordan, C. Osipo, D. Cheng, and J. S. Lewis
RESPONSE: Re: Playing the Old Piano: Another Tune for Endocrine Therapy
J Natl Cancer Inst, April 7, 2004; 96(7): 556 - 557.
[Full Text] [PDF]

Home page
 NEJMHome page
R. C. Coombes, E. Hall, L. J. Gibson, R. Paridaens, J. Jassem, T. Delozier, S. E. Jones, I. Alvarez, G. Bertelli, O. Ortmann, et al.
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
N. Engl. J. Med., March 11, 2004; 350(11): 1081 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. X. Song, C. J. Barnes, Z. Zhang, Y. Bao, R. Kumar, and R. J. Santen
The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor {alpha} to the plasma membrane
PNAS, February 17, 2004; 101(7): 2076 - 2081.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.